Navigation Links
Statistics & Data Corporation Selects MedNet Solutions As Strategic Technology Partner
Date:10/25/2012

MINNETONKA, Minn., Oct. 16, 2012 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, and Statistics & Data Corporation (SDC), a specialized Contract Research Organization (CRO) focused exclusively on delivering biostatistics and data management services to the life sciences industry, are pleased to announce that SDC has chosen MedNet's iMedNet EDC platform as their eClinical solution of choice.  As the latest member of the iMedNet Partner Program, SDC will be able to couple their personalized service and innovative clinical biometrics expertise with iMedNet EDC's extensive and highly configurable eClinical toolset to quickly and effectively support their customers' clinical research initiatives.

"After working together on multiple projects over the past 2 years, SDC is excited to announce the formalization of our partnership with MedNet Solutions," stated Dr. Richard Abelson, President at SDC. "We believe that the iMedNet platform is a next generation eClinical technology, and our team is looking forward to offering the functionality and flexibility of the system as SDC's primary solution to our clients."

"We are extremely pleased to solidify our strategic relationship with SDC – a quality organization committed to exceptional customer service and support," noted John M. (Rob) Robertson, President and CEO of MedNet Solutions.  "iMedNet was selected by SDC after their exhaustive review of the eClinical solutions marketplace...just one example of their keen attention to detail.  It is very gratifying that iMedNet was ultimately selected by them as the best EDC system available to meet their requirements."

For more information on iMedNet EDC or the iMedNet Partner Program, please contact MedNet Solutions. For additional details on SDC's biostatistics and data management services, please contact SDC.

About MedNet Solutions
MedNet Solutions is a leading healthcare technology company specializing in electronic data capture (EDC) and clinical trial management systems (CTMS) designed for the global life sciences market.  MedNet delivers proven, flexible and easy-to-use web-based eClinical solutions that effectively support clinical studies, registries and investigator initiated trials of all types and sizes.  Since 2000, MedNet has successfully supported pharmaceutical, medical device, biotechnology, and contract research organizations (CROs) on clinical research conducted around the world.  These companies trust MedNet to consistently deliver the technology innovation, experience and reliability they need for success.  For more information, please visit www.mednetstudy.com.

About Statistics & Data Corporation
Statistics & Data Corporation (SDC) provides innovative biostatistics and clinical data management services to pharmaceutical, biotechnology, and medical device companies, as well as CRO partners.  SDC is committed to providing experienced teams who take ownership of our clients' needs and provide positive engagement on projects.  SDC delivered on-time on over 99% of key project milestones since 2010, and has a proven track record for rapidly delivering analyses during project closeout (consistently providing top-line analysis within 3 business days of database lock). For more information, please visit www.sdcclinical.com.

Contact Information:

Dirk H. Nelson
Director of Marketing
MedNet Solutions
110 Cheshire Lane, Suite 300
Minnetonka, MN  55305
USA
(763) 258-2735

Jim Townsend
Director, Business Development
Statistics & Data Corporation
21 East 6th Street, Suite 110
Tempe, AZ  85281
USA
(480) 632-5468


'/>"/>
SOURCE MedNet Solutions
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Conatus Pharmaceuticals Appoints Mark F. Morris as Head of Biostatistics
2. Increased Focus on Security Bolsters Growth of Biometrics Market in Asia-Pacific, Finds Frost & Sullivan
3. DARPA director: Revolutionary weapons require strong S&T partnerships
4. MARC travel awards announced for 2012 American Society for Bone & Mineral Research annual meeting
5. British team set to embark on ambitious Antarctic mission to penetrate & sample ancient buried lake
6. Controlling gait of horses may be possible, says key study from Texas A&M
7. NSBRI renews space life sciences graduate programs at MIT, Texas A&M
8. Genetic Engineering & Biotechnology News unveils Biotech Boulevard
9. NSF releases report detailing nationwide and state-by-state R&D activities
10. Symposium: Protein-Folding Diseases: Models & Mechanisms
11. Mining cleanup benefits from Texas A&M expertise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... Summary This report provides all the ... interests and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ...
(Date:3/1/2017)... 2017  Aware, Inc. (NASDAQ: AWRE), a leading supplier ... P. Moberg has resigned, effective March 3, 2017, ... Officer and Treasurer of Aware citing a desire to ... member of the Board of Directors of Aware. ... Officer and co-President, General Counsel has been named Chief ...
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with ... today announced participation at the following conferences: ... Maidstone Life Sciences conference "Cancer Immunotherapy Conference" at the ... York, NY . Agenus will participate in three ... Robert B. Stein , M.D., Ph.D., President, R&D ...
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
(Date:3/23/2017)... , March 23, 2017 NetworkNewsWire ... ... death, putting significant strain on health care systems, in terms ... diagnoses rises, so too does the development of innovative and ... side effects. Among the many types of cancer treatments, a ...
Breaking Biology Technology: